Bifogade filer
Invitation to presentation of Sedana Medical’s interim report for the third quarter 2024
Kurs
-2,58%
Likviditet
1,79 MSEK
Prenumeration
Kalender
| Tid* | ||
| 2025-10-24 | 07:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-18 | 07:00 | Kvartalsrapport 2025-Q2 |
| 2025-05-15 | N/A | Årsstämma |
| 2025-05-06 | 07:00 | Kvartalsrapport 2025-Q1 |
| 2025-02-13 | 07:00 | Bokslutskommuniké 2024 |
| 2024-10-24 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-23 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-23 | - | X-dag ordinarie utdelning SEDANA 0.00 SEK |
| 2024-05-22 | - | Årsstämma |
| 2024-04-25 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-15 | - | Bokslutskommuniké 2023 |
| 2023-10-26 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-21 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-17 | - | X-dag ordinarie utdelning SEDANA 0.00 SEK |
| 2023-05-16 | - | Årsstämma |
| 2023-04-27 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-16 | - | Bokslutskommuniké 2022 |
| 2022-10-25 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-21 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-12 | - | X-dag ordinarie utdelning SEDANA 0.00 SEK |
| 2022-05-11 | - | Årsstämma |
| 2022-04-28 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-11-04 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-19 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-26 | - | Split SEDANA 1:4 |
| 2021-05-11 | - | X-dag ordinarie utdelning SEDANA 0.00 SEK |
| 2021-05-10 | - | Årsstämma |
| 2021-05-06 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-25 | - | Bokslutskommuniké 2020 |
| 2020-11-05 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-25 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-20 | - | X-dag ordinarie utdelning SEDANA 0.00 SEK |
| 2020-05-19 | - | Årsstämma |
| 2020-05-07 | - | Kvartalsrapport 2020-Q1 |
| 2020-03-05 | - | Bokslutskommuniké 2019 |
| 2019-11-13 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-22 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-29 | - | X-dag ordinarie utdelning SEDANA 0.00 SEK |
| 2019-05-28 | - | Årsstämma |
| 2019-05-08 | - | Kvartalsrapport 2019-Q1 |
| 2019-03-21 | - | Bokslutskommuniké 2018 |
| 2018-11-22 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-30 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-23 | - | X-dag ordinarie utdelning SEDANA 0.00 SEK |
| 2018-05-22 | - | Årsstämma |
| 2018-05-22 | - | Kvartalsrapport 2018-Q1 |
| 2018-03-27 | - | Bokslutskommuniké 2017 |
| 2017-11-30 | - | Kvartalsrapport 2017-Q3 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Mid Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Sedana Medical AB (publ) plans to present its interim report for the third quarter of 2024 on Thursday October 24 at 13:30 CET.
According to the financial calendar, Sedana Medical plans to publish the interim report for the third quarter 2024 on Thursday October 24 at approximately 07.00 CET. Sedana Medical hereby invites to a presentation of the report on the same day, where the CEO Johannes Doll will present the report in English together with Johan Spetz, CFO, and Peter Sackey, CMO, as well as answer questions.
Date: Thursday, October 24, 2024
Time (CET): 13:30
More info and link to the audiocast: https://www.finwire.tv/webcast/sedana-medical/q3-2024/
If you wish to participate via teleconference: +46 8 5050 0828. Meeting ID: 836 8155 4078 followed by #.
Welcome!
For additional information, please contact:
Johannes Doll, CEO, +46 (0)76 303 66 66
Johan Spetz, CFO, +46 (0)730 36 37 89
ir@sedanamedical.com
About Sedana Medical
Sedana Medical AB (publ) is a pioneer medtech and pharmaceutical company focused on inhaled sedation to improve the patient’s life during and beyond sedation. Through the combined strengths of the medical device Sedaconda ACD and the pharmaceutical Sedaconda (isoflurane), Sedana Medical provides inhaled sedation for mechanically ventilated patients in intensive care.
Sedana Medical has direct sales in Benelux, France, Germany, Great Britain, the Nordics, and Spain. In other parts of Europe as well as in Asia, Australia, Canada, and South- and Central America, the company works with external distributors.
Sedana Medical was founded in 2005, is listed on Nasdaq Stockholm (SEDANA) and headquartered in Stockholm, Sweden.